The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-(4-(3-(4-methoxyphenyl)-1H-pyrazolo[3,4-b]pyridin-5-yl)phenyl)urea ID: ALA4872233
PubChem CID: 164619035
Max Phase: Preclinical
Molecular Formula: C20H17N5O2
Molecular Weight: 359.39
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COc1ccc(-c2n[nH]c3ncc(-c4ccc(NC(N)=O)cc4)cc23)cc1
Standard InChI: InChI=1S/C20H17N5O2/c1-27-16-8-4-13(5-9-16)18-17-10-14(11-22-19(17)25-24-18)12-2-6-15(7-3-12)23-20(21)26/h2-11H,1H3,(H3,21,23,26)(H,22,24,25)
Standard InChI Key: APFOPVHPNQUBPI-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
30.8455 -4.5399 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.8443 -5.3595 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.5524 -5.7684 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.5506 -4.1311 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.2592 -4.5363 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.2595 -5.3595 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.0424 -5.6137 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.5262 -4.9475 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.0420 -4.2818 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.2941 -3.5059 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.0947 -3.3369 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.3471 -2.5604 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.7998 -1.9524 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.9970 -2.1260 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.7483 -2.9022 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.1398 -4.1317 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.1409 -3.3134 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.4339 -2.9050 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.7253 -3.3138 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.7282 -4.1352 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.4357 -4.5399 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.0170 -2.9063 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.3099 -3.3161 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.6016 -2.9086 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.3112 -4.1332 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
34.0511 -1.1747 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
34.8501 -1.0035 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 10 1 0
9 10 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
1 16 1 0
19 22 1 0
22 23 1 0
23 24 1 0
23 25 2 0
13 26 1 0
26 27 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 359.39Molecular Weight (Monoisotopic): 359.1382AlogP: 3.79#Rotatable Bonds: 4Polar Surface Area: 105.92Molecular Species: NEUTRALHBA: 4HBD: 3#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 4#RO5 Violations (Lipinski): ┄CX Acidic pKa: 9.86CX Basic pKa: 1.91CX LogP: 2.87CX LogD: 2.87Aromatic Rings: 4Heavy Atoms: 27QED Weighted: 0.52Np Likeness Score: -1.28
References 1. Park A, Hwang J, Lee JY, Heo EJ, Na YJ, Kang S, Jeong KS, Kim KY, Shin SJ, Lee H.. (2021) Synthesis of novel 1H-Pyrazolo[3,4-b]pyridine derivatives as DYRK 1A/1B inhibitors., 47 [PMID:34182093 ] [10.1016/j.bmcl.2021.128226 ]